Literature DB >> 21349417

Surgery for gastroenteropancreatic neuroendocrine tumors (GEPNETS).

J Philip Boudreaux1.   

Abstract

The only therapy with the potential for complete cure of patients with gastroenteropancreatic neuroendocrine tumors is complete surgical excision. Surgical options per se are often dictated by the tumor's site of origin, degree of tumor burden, and overall health or debility of the individual patient. This article considers different options based on the type of tumor and site of origin.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21349417     DOI: 10.1016/j.ecl.2010.12.004

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  4 in total

1.  The treatment of neuroendocrine tumors with long-acting somatostatin analogs: a single center experience with lanreotide autogel.

Authors:  A Bianchi; L De Marinis; A Fusco; F Lugli; L Tartaglione; D Milardi; M Mormando; A P Lassandro; R Paragliola; C A Rota; S Della Casa; S M Corsello; M G Brizi; A Pontecorvi
Journal:  J Endocrinol Invest       Date:  2011-11-07       Impact factor: 4.256

Review 2.  Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.

Authors:  Krystallenia I Alexandraki; Gregory Kaltsas
Journal:  Endocrine       Date:  2011-11-29       Impact factor: 3.633

3.  The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.

Authors:  Robert A Ramirez; David T Beyer; Aman Chauhan; J Philip Boudreaux; Yi-Zarn Wang; Eugene A Woltering
Journal:  Oncologist       Date:  2016-05-25

Review 4.  Management of Gastrointestinal Neuroendocrine Tumors.

Authors:  Rongzhi Wang; Rui Zheng-Pywell; H Alexander Chen; James A Bibb; Herbert Chen; J Bart Rose
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2019-10-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.